Trip13 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318331 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIP13 mRNA CTD PMID:22079256 Trip13 Rat 1,1-dichloroethene increases expression ISO RGD:1318332 6480464 vinylidene chloride results in increased expression of TRIP13 mRNA CTD PMID:26682919 Trip13 Rat 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene multiple interactions ISO RGD:1318332 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Trip13 Rat 1,2-dichloroethane decreases expression ISO RGD:1318332 6480464 ethylene dichloride results in decreased expression of TRIP13 mRNA CTD PMID:28960355 Trip13 Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of TRIP13 mRNA CTD PMID:30723492 Trip13 Rat 17alpha-ethynylestradiol increases expression ISO RGD:1318332 6480464 Ethinyl Estradiol results in increased expression of TRIP13 mRNA CTD PMID:17942748 Trip13 Rat 17alpha-ethynylestradiol multiple interactions ISO RGD:1318332 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIP13 mRNA CTD PMID:17942748 Trip13 Rat 17beta-estradiol increases expression ISO RGD:1318331 6480464 Estradiol results in increased expression of TRIP13 mRNA CTD PMID:16474171|PMID:19167446 Trip13 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1318332 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Trip13 Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1318332 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Trip13 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318332 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIP13 mRNA CTD PMID:17942748 Trip13 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318331 6480464 Tetrachlorodibenzodioxin affects the expression of TRIP13 mRNA CTD PMID:22574217 Trip13 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318332 6480464 Tetrachlorodibenzodioxin results in increased expression of TRIP13 mRNA CTD PMID:19465110|PMID:19770486 Trip13 Rat 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1318331 6480464 2,3-dimethoxy-1,4-naphthoquinone results in increased expression of TRIP13 mRNA CTD PMID:17547211 Trip13 Rat 2,4,4'-trichlorobiphenyl multiple interactions ISO RGD:1318332 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Trip13 Rat 2-palmitoylglycerol increases expression ISO RGD:1318331 6480464 2-palmitoylglycerol results in increased expression of TRIP13 mRNA CTD PMID:37199045 Trip13 Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TRIP13 mRNA CTD PMID:23196670 Trip13 Rat 3-methylcholanthrene increases expression ISO RGD:1318332 6480464 Methylcholanthrene results in increased expression of TRIP13 mRNA CTD PMID:20713471 Trip13 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1318331 6480464 bisphenol S results in increased expression of TRIP13 mRNA CTD PMID:27685785 Trip13 Rat 4-hydroxynon-2-enal decreases expression ISO RGD:1318332 6480464 4-hydroxy-2-nonenal results in decreased expression of TRIP13 mRNA CTD PMID:19191707 Trip13 Rat 4-hydroxynon-2-enal increases expression ISO RGD:1318332 6480464 4-hydroxy-2-nonenal results in increased expression of TRIP13 mRNA CTD PMID:19191707 Trip13 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TRIP13 mRNA CTD PMID:24780913 Trip13 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of TRIP13 mRNA CTD PMID:31881176 Trip13 Rat acetohydrazide decreases expression ISO RGD:1318332 6480464 acetylhydrazine results in decreased expression of TRIP13 mRNA CTD PMID:15282401 Trip13 Rat acrolein multiple interactions ISO RGD:1318331 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... CTD PMID:32699268 Trip13 Rat acrylamide decreases expression ISO RGD:1318331 6480464 Acrylamide results in decreased expression of TRIP13 mRNA CTD PMID:32763439 Trip13 Rat aflatoxin B1 affects expression ISO RGD:1318331 6480464 Aflatoxin B1 affects the expression of TRIP13 protein CTD PMID:20106945 Trip13 Rat aflatoxin B1 multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of TRIP13 mRNA CTD PMID:25450479 Trip13 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TRIP13 mRNA CTD PMID:23630614 Trip13 Rat all-trans-retinoic acid decreases expression ISO RGD:1318331 6480464 Tretinoin results in decreased expression of TRIP13 mRNA CTD PMID:33167477 Trip13 Rat alpha-pinene multiple interactions ISO RGD:1318331 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... CTD PMID:32699268 Trip13 Rat arsenite(3-) decreases expression ISO RGD:1318332 6480464 arsenite results in decreased expression of TRIP13 mRNA CTD PMID:18929588 Trip13 Rat arsenous acid increases expression ISO RGD:1318331 6480464 Arsenic Trioxide results in increased expression of TRIP13 mRNA CTD PMID:17547211 Trip13 Rat atrazine decreases expression ISO RGD:1318331 6480464 Atrazine results in decreased expression of TRIP13 mRNA CTD PMID:22378314 Trip13 Rat azathioprine decreases expression ISO RGD:1318331 6480464 Azathioprine results in decreased expression of TRIP13 mRNA CTD PMID:22623647 Trip13 Rat benzo[a]pyrene increases expression ISO RGD:1318332 6480464 Benzo(a)pyrene results in increased expression of TRIP13 mRNA CTD PMID:20713471 Trip13 Rat benzo[a]pyrene increases expression ISO RGD:1318331 6480464 Benzo(a)pyrene results in increased expression of TRIP13 mRNA CTD PMID:32234424 Trip13 Rat benzo[a]pyrene decreases expression ISO RGD:1318332 6480464 Benzo(a)pyrene results in decreased expression of TRIP13 mRNA CTD PMID:19770486 Trip13 Rat benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1318331 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRIP13 mRNA CTD PMID:20382639 Trip13 Rat benzo[b]fluoranthene increases expression ISO RGD:1318332 6480464 benzo(b)fluoranthene results in increased expression of TRIP13 mRNA CTD PMID:26377693 Trip13 Rat bis(2-chloroethyl) sulfide decreases expression ISO RGD:1318331 6480464 Mustard Gas results in decreased expression of TRIP13 mRNA CTD PMID:25102026 Trip13 Rat bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1318332 6480464 Diethylhexyl Phthalate results in decreased expression of TRIP13 mRNA CTD PMID:34319233 Trip13 Rat bisphenol A increases expression ISO RGD:1318331 6480464 bisphenol A results in increased expression of TRIP13 mRNA CTD PMID:16474171 Trip13 Rat bisphenol A decreases expression ISO RGD:1318331 6480464 bisphenol A results in decreased expression of TRIP13 mRNA CTD PMID:29275510 Trip13 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TRIP13 mRNA CTD PMID:30816183|PMID:32528016 Trip13 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TRIP13 mRNA CTD PMID:25181051 Trip13 Rat cadmium dichloride increases expression ISO RGD:1318331 6480464 Cadmium Chloride results in increased expression of TRIP13 mRNA CTD PMID:38382870 Trip13 Rat calcitriol multiple interactions ISO RGD:1318331 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TRIP13 mRNA CTD PMID:21592394 Trip13 Rat calcitriol decreases expression ISO RGD:1318331 6480464 Calcitriol results in decreased expression of TRIP13 mRNA CTD PMID:21592394 Trip13 Rat carbon nanotube increases expression ISO RGD:1318332 6480464 Nanotubes, Carbon analog results in increased expression of TRIP13 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 Trip13 Rat carbon nanotube decreases expression ISO RGD:1318332 6480464 Nanotubes, Carbon results in decreased expression of TRIP13 mRNA CTD PMID:25620056 Trip13 Rat chlorpyrifos decreases expression ISO RGD:1318332 6480464 Chlorpyrifos results in decreased expression of TRIP13 mRNA CTD PMID:37019170 Trip13 Rat chromium(6+) multiple interactions ISO RGD:1318331 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression more ... CTD PMID:38479592 Trip13 Rat cisplatin affects response to substance ISO RGD:1318331 6480464 TRIP13 protein affects the susceptibility to Cisplatin CTD PMID:16217747 Trip13 Rat cobalt dichloride decreases expression ISO RGD:1318331 6480464 cobaltous chloride results in decreased expression of TRIP13 mRNA CTD PMID:19320972|PMID:19376846 Trip13 Rat copper atom increases expression ISO RGD:1318332 6480464 Copper results in increased expression of TRIP13 mRNA CTD PMID:17205981 Trip13 Rat copper(0) increases expression ISO RGD:1318332 6480464 Copper results in increased expression of TRIP13 mRNA CTD PMID:17205981 Trip13 Rat coumestrol multiple interactions ISO RGD:1318331 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA; [Coumestrol co-treated with resveratrol] more ... CTD PMID:19167446 Trip13 Rat coumestrol increases expression ISO RGD:1318331 6480464 Coumestrol results in increased expression of TRIP13 mRNA CTD PMID:19167446 Trip13 Rat cyclosporin A decreases expression ISO RGD:1318331 6480464 Cyclosporine results in decreased expression of TRIP13 mRNA CTD PMID:19159671|PMID:25562108 Trip13 Rat DDE increases expression ISO RGD:1318331 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of TRIP13 mRNA CTD PMID:38568856 Trip13 Rat diarsenic trioxide increases expression ISO RGD:1318331 6480464 Arsenic Trioxide results in increased expression of TRIP13 mRNA CTD PMID:17547211 Trip13 Rat diazinon increases methylation ISO RGD:1318331 6480464 Diazinon results in increased methylation of TRIP13 gene CTD PMID:22964155 Trip13 Rat dibenzo[a,l]pyrene decreases expression ISO RGD:1318332 6480464 dibenzo(a,l)pyrene results in decreased expression of TRIP13 mRNA CTD PMID:25908611 Trip13 Rat dibutyl phthalate decreases expression ISO RGD:1318332 6480464 Dibutyl Phthalate results in decreased expression of TRIP13 mRNA CTD PMID:21266533 Trip13 Rat dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of TRIP13 mRNA CTD PMID:23153324 Trip13 Rat diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of TRIP13 mRNA CTD PMID:21161181 Trip13 Rat dioxygen decreases expression ISO RGD:1318331 6480464 Oxygen deficiency results in decreased expression of TRIP13 mRNA CTD PMID:26516004 Trip13 Rat Enterolactone multiple interactions ISO RGD:1318331 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA CTD PMID:19167446 Trip13 Rat enzyme inhibitor multiple interactions ISO RGD:1318331 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... CTD PMID:23301498 Trip13 Rat ethyl methanesulfonate decreases expression ISO RGD:1318331 6480464 Ethyl Methanesulfonate results in decreased expression of TRIP13 mRNA CTD PMID:23649840 Trip13 Rat folic acid multiple interactions ISO RGD:1318331 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TRIP13 mRNA CTD PMID:24657277 Trip13 Rat formaldehyde decreases expression ISO RGD:1318331 6480464 Formaldehyde results in decreased expression of TRIP13 mRNA CTD PMID:23649840 Trip13 Rat genistein increases expression ISO RGD:1318331 6480464 Genistein results in increased expression of TRIP13 mRNA CTD PMID:16474171 Trip13 Rat heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of TRIP13 mRNA CTD PMID:23153324 Trip13 Rat ivermectin decreases expression ISO RGD:1318331 6480464 Ivermectin results in decreased expression of TRIP13 protein CTD PMID:32959892 Trip13 Rat Lasiocarpine increases expression ISO RGD:1318331 6480464 lasiocarpine results in increased expression of TRIP13 mRNA CTD PMID:32234424 Trip13 Rat leflunomide decreases expression ISO RGD:1318331 6480464 leflunomide results in decreased expression of TRIP13 mRNA CTD PMID:28988120 Trip13 Rat lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of TRIP13 mRNA CTD PMID:35283115 Trip13 Rat linezolid decreases expression EXP 6480464 Linezolid results in decreased expression of TRIP13 mRNA CTD PMID:21296123 Trip13 Rat mercury atom increases expression ISO RGD:1318331 6480464 Mercury results in increased expression of TRIP13 mRNA CTD PMID:17547211 Trip13 Rat mercury(0) increases expression ISO RGD:1318331 6480464 Mercury results in increased expression of TRIP13 mRNA CTD PMID:17547211 Trip13 Rat methotrexate multiple interactions ISO RGD:1318331 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TRIP13 mRNA CTD PMID:24657277 Trip13 Rat methyl methanesulfonate decreases expression ISO RGD:1318331 6480464 Methyl Methanesulfonate results in decreased expression of TRIP13 mRNA CTD PMID:23649840 Trip13 Rat mirex increases expression EXP 6480464 Mirex results in increased expression of TRIP13 mRNA CTD PMID:23153324 Trip13 Rat N-nitrosodiethylamine increases expression ISO RGD:1318332 6480464 Diethylnitrosamine results in increased expression of TRIP13 mRNA CTD PMID:17854601 Trip13 Rat N-nitrosodiethylamine multiple interactions ISO RGD:1318332 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TRIP13 mRNA] CTD PMID:17854601 Trip13 Rat N-Nitrosopyrrolidine decreases expression ISO RGD:1318331 6480464 N-Nitrosopyrrolidine results in decreased expression of TRIP13 mRNA CTD PMID:32234424 Trip13 Rat nickel atom increases expression ISO RGD:1318331 6480464 Nickel results in increased expression of TRIP13 mRNA CTD PMID:25583101 Trip13 Rat niclosamide decreases expression ISO RGD:1318331 6480464 Niclosamide results in decreased expression of TRIP13 mRNA CTD PMID:28284560 Trip13 Rat okadaic acid increases expression ISO RGD:1318331 6480464 Okadaic Acid results in increased expression of TRIP13 mRNA CTD PMID:38832940 Trip13 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TRIP13 mRNA CTD PMID:25729387 Trip13 Rat ozone increases expression ISO RGD:1318332 6480464 Ozone results in increased expression of TRIP13 mRNA CTD PMID:25658374 Trip13 Rat ozone multiple interactions ISO RGD:1318331 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... CTD PMID:32699268 Trip13 Rat ozone multiple interactions ISO RGD:1318332 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... CTD PMID:24381131|PMID:25658374|PMID:27106289|PMID:34911549 Trip13 Rat paracetamol affects expression ISO RGD:1318332 6480464 Acetaminophen affects the expression of TRIP13 mRNA CTD PMID:17562736 Trip13 Rat paracetamol increases expression ISO RGD:1318331 6480464 Acetaminophen results in increased expression of TRIP13 mRNA CTD PMID:22230336 Trip13 Rat PCB138 multiple interactions ISO RGD:1318332 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Trip13 Rat perfluorooctanoic acid decreases expression ISO RGD:1318331 6480464 perfluorooctanoic acid results in decreased expression of TRIP13 mRNA CTD PMID:36326898 Trip13 Rat phenethyl isothiocyanate decreases expression ISO RGD:1318331 6480464 phenethyl isothiocyanate results in decreased expression of TRIP13 mRNA CTD PMID:26678675 Trip13 Rat phenobarbital affects expression ISO RGD:1318332 6480464 Phenobarbital affects the expression of TRIP13 mRNA CTD PMID:23091169 Trip13 Rat picoxystrobin increases expression ISO RGD:1318331 6480464 picoxystrobin results in increased expression of TRIP13 mRNA CTD PMID:33512557 Trip13 Rat pirinixic acid multiple interactions ISO RGD:1318331 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Trip13 Rat pirinixic acid increases expression ISO RGD:1318332 6480464 pirinixic acid results in increased expression of TRIP13 mRNA CTD PMID:18445702|PMID:23811191 Trip13 Rat potassium chromate multiple interactions ISO RGD:1318331 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIP13 mRNA CTD PMID:22079256 Trip13 Rat potassium chromate decreases expression ISO RGD:1318331 6480464 potassium chromate(VI) results in decreased expression of TRIP13 mRNA CTD PMID:22079256 Trip13 Rat quercetin affects expression ISO RGD:1318331 6480464 Quercetin affects the expression of TRIP13 mRNA CTD PMID:21632981 Trip13 Rat resveratrol multiple interactions ISO RGD:1318331 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of TRIP13 mRNA CTD PMID:19167446 Trip13 Rat resveratrol increases expression ISO RGD:1318331 6480464 resveratrol results in increased expression of TRIP13 mRNA CTD PMID:19167446 Trip13 Rat rotenone increases expression ISO RGD:1318331 6480464 Rotenone results in increased expression of TRIP13 mRNA CTD PMID:33512557 Trip13 Rat silicon dioxide decreases expression ISO RGD:1318331 6480464 Silicon Dioxide analog results in decreased expression of TRIP13 mRNA CTD PMID:23806026 Trip13 Rat silicon dioxide increases expression ISO RGD:1318332 6480464 Silicon Dioxide results in increased expression of TRIP13 mRNA CTD PMID:29341224 Trip13 Rat sodium arsenite affects expression ISO RGD:1318331 6480464 sodium arsenite affects the expression of TRIP13 mRNA CTD PMID:29301061 Trip13 Rat sodium arsenite decreases expression ISO RGD:1318331 6480464 sodium arsenite results in decreased expression of TRIP13 mRNA; sodium arsenite results in decreased expression more ... CTD PMID:30528433|PMID:38568856 Trip13 Rat sodium arsenite increases expression ISO RGD:1318331 6480464 sodium arsenite results in increased expression of TRIP13 mRNA CTD PMID:34032870 Trip13 Rat sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of TRIP13 mRNA CTD PMID:25993096 Trip13 Rat sodium fluoride increases expression ISO RGD:1318332 6480464 Sodium Fluoride results in increased expression of TRIP13 protein CTD PMID:28918527 Trip13 Rat sulforaphane multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of TRIP13 mRNA CTD PMID:25450479 Trip13 Rat sunitinib decreases expression ISO RGD:1318331 6480464 Sunitinib results in decreased expression of TRIP13 mRNA CTD PMID:31533062 Trip13 Rat tacrolimus hydrate increases expression ISO RGD:1318332 6480464 Tacrolimus results in increased expression of TRIP13 mRNA CTD PMID:29362864 Trip13 Rat testosterone multiple interactions ISO RGD:1318331 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TRIP13 mRNA CTD PMID:21592394 Trip13 Rat testosterone decreases expression ISO RGD:1318331 6480464 Testosterone results in decreased expression of TRIP13 mRNA CTD PMID:21592394 Trip13 Rat tetrachloromethane affects expression ISO RGD:1318332 6480464 Carbon Tetrachloride affects the expression of TRIP13 mRNA CTD PMID:17484886 Trip13 Rat tetrachloromethane increases expression ISO RGD:1318332 6480464 Carbon Tetrachloride results in increased expression of TRIP13 mRNA CTD PMID:31919559 Trip13 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TRIP13 mRNA CTD PMID:23411599 Trip13 Rat titanium dioxide increases expression ISO RGD:1318332 6480464 titanium dioxide results in increased expression of TRIP13 mRNA CTD PMID:23557971 Trip13 Rat titanium dioxide decreases methylation ISO RGD:1318332 6480464 titanium dioxide results in decreased methylation of TRIP13 gene CTD PMID:35295148 Trip13 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TRIP13 mRNA CTD PMID:25729387 Trip13 Rat trimellitic anhydride increases expression ISO RGD:1318332 6480464 trimellitic anhydride results in increased expression of TRIP13 mRNA CTD PMID:19042947 Trip13 Rat troglitazone decreases expression ISO RGD:1318331 6480464 troglitazone results in decreased expression of TRIP13 mRNA CTD PMID:19140230 Trip13 Rat trovafloxacin decreases expression ISO RGD:1318332 6480464 trovafloxacin results in decreased expression of TRIP13 mRNA CTD PMID:35537566 Trip13 Rat tunicamycin decreases expression ISO RGD:1318331 6480464 Tunicamycin results in decreased expression of TRIP13 mRNA CTD PMID:29453283 Trip13 Rat urethane decreases expression ISO RGD:1318331 6480464 Urethane results in decreased expression of TRIP13 mRNA CTD PMID:28818685 Trip13 Rat valproic acid decreases expression ISO RGD:1318331 6480464 Valproic Acid results in decreased expression of TRIP13 mRNA CTD PMID:19101580 Trip13 Rat valproic acid affects expression ISO RGD:1318331 6480464 Valproic Acid affects the expression of TRIP13 mRNA CTD PMID:25979313 Trip13 Rat zinc atom increases expression ISO RGD:1318331 6480464 Zinc deficiency results in increased expression of TRIP13 mRNA CTD PMID:22171008 Trip13 Rat zinc(0) increases expression ISO RGD:1318331 6480464 Zinc deficiency results in increased expression of TRIP13 mRNA CTD PMID:22171008 Trip13 Rat zoledronic acid decreases expression ISO RGD:1318331 6480464 zoledronic acid results in decreased expression of TRIP13 mRNA CTD PMID:24714768